drugset / Trial / NCT04738045
Comparison of Remdesivir Versus Lopinavir/ Ritonavir and Remdesivir Combination in COVID-19 Patients
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Comparison outcomes of a large cohort of moderate and severe COVID-19 patients received remdesivir alone with patients who received remdesivir in combination with lopinavir/ ritonavir in addition to standard management.
Timeline
- Start
- 2020-11-01
- Primary completion
- 2021-03-28
- Completion
- 2021-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lopinavir | Other / unclassified | 400 mg | Intravenous |
| Comparator | Remdesivir | Small molecule | 100 mg | Intravenous |
| Subject | Ritonavir | Other / unclassified | 100 mg | Intravenous |